Why is Boston Bio falling/rising?

As of 20-Aug, Boston Bio Systems Ltd is experiencing a decline in its stock price, currently at 8.01, which reflects a decrease of 0.08 or 0.99%. The stock has underperformed its sector today by 4.8%, despite being higher than its 5-day, 20-day, and 50-day moving averages. However, it is lower than its 100-day and 200-day moving averages. In the past week, the stock has gained 0.25%, but over the past month, it has seen a more significant increase of 10.18%. Notably, there has been a drastic drop in investor participation, with delivery volume falling by 99.29% against the 5-day average, indicating reduced trading activity. Unfortunately, there is no information available regarding positive or negative factors impacting the stock.
In the broader market context, the Sensex has increased by 1.64% over the past week, suggesting that Boston Bio's short-term performance is lagging behind the benchmark. While the medical equipment sector has gained by 3.85%, Boston Bio's performance does not align with this upward trend, further highlighting its struggles in the current market environment. The stock's liquidity remains adequate for trading, but the significant drop in delivery volume raises concerns about investor interest and confidence in the stock's future performance.